Development of therapeutic proteins: advances and challenges

被引:35
作者
Akash, Muhammad Sajid Hamid [1 ,2 ]
Rehman, Kanwal [3 ]
Tariq, Muhammad [1 ]
Chen, Shuqing [1 ]
机构
[1] Zhejiang Univ, Coll Pharmaceut Sci, Inst Pharmacol Toxicol & Biochem Pharmaceut, Hangzhou 310003, Zhejiang, Peoples R China
[2] Govt Coll Univ Faisalabad, Fac Pharmaceut Sci, Faisalabad, Pakistan
[3] Univ Agr Faisalabad, Inst Pharm Physiol & Pharmacol, Faisalabad, Pakistan
关键词
Therapeutic proteins; protein classification; production of therapeutic proteins; pharmacokinetics of therapeutic proteins; immunogenicity; protein stability; protein degradation; INTERLEUKIN-1 RECEPTOR ANTAGONIST; TYPE-2; DIABETES-MELLITUS; PLACEBO-CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL; REGULATORY T-CELLS; RHEUMATOID-ARTHRITIS; DRUG-DELIVERY; GASTROINTESTINAL ABSORPTION; TRANSEPITHELIAL TRANSPORT; MONOCLONAL-ANTIBODIES;
D O I
10.3906/biy-1411-8
中图分类号
Q [生物科学];
学科分类号
090105 [作物生产系统与生态工程];
摘要
Therapeutic proteins have shown to be effective against a variety of diseases. Pharmaceutical companies are progressively focusing on research using proteins in search of novel effective therapeutics. The significant attention by researchers has resulted in considerable advances in the production and usage of therapeutic proteins in recent years. In the current study we focused on the understanding of therapeutic proteins and their impact on the human health care system. Advancements in the field of biotechnology have increased and facilitated the production of therapeutically significant proteins to combat various fatal diseases. Although protein-based therapeutics have taken center stage in drug discovery and development and enhanced safety for human beings, certain challenges remain, including safety and immunogenicity issues, protein stability, and degradation issues. We made an attempt to discuss all possible factors that are linked with the basis of therapeutic proteins and possible challenges that are currently being faced by scientists during the development of these therapeutic proteins.
引用
收藏
页码:343 / 358
页数:16
相关论文
共 150 条
[1]
ABDELRAZZAK Z, 1993, MOL PHARMACOL, V44, P707
[2]
Purification and biochemical characterization of an extracellular lipase from psychrotolerant Pseudomonas fluorescens KE38 [J].
Adan Gokbulut, Aysun ;
Arslanoglu, Alper .
TURKISH JOURNAL OF BIOLOGY, 2013, 37 (05) :538-546
[3]
Optimization of E. coli culture conditions for efficient DNA uptake by electroporation [J].
Ahmad, Irfan ;
Rubbab, Tehseen ;
Deeba, Farah ;
Naqvi, Syed Muhammad Saqlan .
TURKISH JOURNAL OF BIOLOGY, 2014, 38 (05) :568-573
[4]
Purification of antioxidant protein isolated from Peganum harmala and its protective effect against CCl4 toxicity in rats [J].
Ahmed, Hanaa ;
Abu El Zahab, Helal ;
Alswiai, Gamia .
TURKISH JOURNAL OF BIOLOGY, 2013, 37 (01) :39-48
[5]
Polymeric-based particulate systems for delivery of therapeutic proteins [J].
Akash, Muhammad Sajid Hamid ;
Rehman, Kanwal ;
Chen, Shuqing .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2016, 21 (03) :367-378
[6]
Natural and Synthetic Polymers as Drug Carriers for Delivery of Therapeutic Proteins [J].
Akash, Muhammad Sajid Hamid ;
Rehman, Kanwal ;
Chen, Shuqing .
POLYMER REVIEWS, 2015, 55 (03) :371-406
[7]
Pluronic F127-Based Thermosensitive Gels for Delivery of Therapeutic Proteins and Peptides [J].
Akash, Muhammad Sajid Hamid ;
Rehman, Kanwal ;
Chen, Shuqing .
POLYMER REVIEWS, 2014, 54 (04) :573-597
[8]
Spice plant Allium cepa: Dietary supplement for treatment of type 2 diabetes mellitus [J].
Akash, Muhammad Sajid Hamid ;
Rehman, Kanwal ;
Chen, Shuqing .
NUTRITION, 2014, 30 (10) :1128-1137
[9]
Effects of coffee on type 2 diabetes mellitus [J].
Akash, Muhammad Sajid Hamid ;
Rehman, Kanwal ;
Chen, Shuqing .
NUTRITION, 2014, 30 (7-8) :755-763
[10]
Assessment of release kinetics, stability and polymer interaction of poloxamer 407-based thermosensitive gel of interleukin-1 receptor antagonist [J].
Akash, Muhammad Sajid Hamid ;
Rehman, Kanwal ;
Sun, Hongying ;
Chen, Shuqing .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2014, 19 (03) :278-284